These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica. East-Innis AD; Thompson DS West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894 [TBL] [Abstract][Full Text] [Related]
10. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Cartotto R Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247 [TBL] [Abstract][Full Text] [Related]
11. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis. Ririe MR; Blaylock RC; Morris SE; Jung JY J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282 [TBL] [Abstract][Full Text] [Related]
13. [Stevens-Johnson syndrome and toxic epidermal necrolysis]. Oliveira A; Sanches M; Selores M Acta Med Port; 2011 Dec; 24 Suppl 4():995-1002. PubMed ID: 22863510 [TBL] [Abstract][Full Text] [Related]
14. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin. Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867 [TBL] [Abstract][Full Text] [Related]
15. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features. Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722 [TBL] [Abstract][Full Text] [Related]
16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
18. Mortality and use of the auxiliary score in extensive toxic epidermal necrolysis patients admitted to an adult burns referral centre. Mahar PD; Wasiak J; Cleland H; Watters D; Paul E; Marsh P; Gin D Dermatology; 2013; 227(2):180-5. PubMed ID: 24080507 [TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention. Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495 [TBL] [Abstract][Full Text] [Related]
20. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN. Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]